CYDAN, LLC

Profile

Company Names

CYDAN, LLC

Addresses

300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE, MA 02139

16 CONANT ROAD, LINCOLN, MA 01773

Phone Numbers

617-953-9081
617-231-6020

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$6,601,336.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-03-28 
$6,601,336.00 
$26,333,836.00 
$19,732,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPH 
M. 
ADAMS 
EXECUTIVE OFFICER
CYDAN, LLC   |  IMARA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
CRISTINA 
 
CSIMMA 
EXECUTIVE OFFICER, DIRECTOR
CYDAN, LLC   |  SENECA BIOPHARMA, INC.   |  PALISADE BIO, INC.
BARBARA 
 
DALTON 
DIRECTOR
CELLADON CORP   |  CYDAN, LLC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  IMARA INC.   |  MORPHIC HOLDING, LLC   |  COMPLEXA INC.   |  CYDAN II, INC.   |  MAGNOLIA NEUROSCIENCES CORP
DEBORAH 
 
GERAGHTY 
EXECUTIVE OFFICER
CYDAN, LLC   |  REALTA LIFE SCIENCES, INC.
JAMES 
 
MCARTHUR 
EXECUTIVE OFFICER
CYDAN, LLC   |  CYDAN II, INC.   |  AGM CAPITAL FUND II, LLC   |  PEPGEN INC.
DAVID 
 
MOTT 
DIRECTOR
3-V BIOSCIENCES, INC.   |  TESARO, INC.   |  ARDELYX, INC.   |  ZYNGENIA, INC.   |  OMTHERA PHARMACEUTICALS, INC.   |  MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  EDIMER PHARMACEUTICALS, INC.   |  PROSENSA HOLDING N.V.   |  ADAPTIMMUNE LTD   |  MERSANA THERAPEUTICS, INC.   |  XTUIT PHARMACEUTICALS, INC.   |  IMARA INC.   |  COMPLEXA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
SARA 
 
NAYEEM 
DIRECTOR
MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  MERSANA THERAPEUTICS, INC.   |  IMARA INC.   |  CYDAN II, INC.   |  CENTREXION THERAPEUTICS CORP   |  TIBURIO THERAPEUTICS INC.   |  VANQUA BIO, INC.   |  NORMUNITY HOLDING COMPANY, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-10-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
2013-04-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#